Quantbot Technologies LP Sells 6,708 Shares of Quanterix Co. (NASDAQ:QTRX)

Quantbot Technologies LP reduced its stake in shares of Quanterix Co. (NASDAQ:QTRX) by 68.3% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,113 shares of the company’s stock after selling 6,708 shares during the quarter. Quantbot Technologies LP’s holdings in Quanterix were worth $40,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also modified their holdings of the company. Price T Rowe Associates Inc. MD boosted its position in Quanterix by 3.1% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 39,916 shares of the company’s stock valued at $941,000 after buying an additional 1,186 shares during the last quarter. Comerica Bank boosted its holdings in Quanterix by 44,205.6% in the first quarter. Comerica Bank now owns 7,975 shares of the company’s stock valued at $188,000 after acquiring an additional 7,957 shares during the last quarter. Assenagon Asset Management S.A. acquired a new stake in Quanterix in the second quarter worth about $3,389,000. Baillie Gifford & Co. raised its holdings in Quanterix by 1.6% during the 2nd quarter. Baillie Gifford & Co. now owns 633,460 shares of the company’s stock worth $8,368,000 after purchasing an additional 10,105 shares during the last quarter. Finally, Easterly Investment Partners LLC lifted its position in Quanterix by 779.9% during the 2nd quarter. Easterly Investment Partners LLC now owns 692,746 shares of the company’s stock valued at $9,151,000 after purchasing an additional 614,012 shares during the period. Institutional investors and hedge funds own 86.48% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on QTRX shares. Scotiabank lowered their price target on shares of Quanterix from $32.00 to $28.00 and set a “sector outperform” rating for the company in a research report on Monday, August 12th. TD Cowen lifted their target price on shares of Quanterix from $13.50 to $16.00 and gave the stock a “hold” rating in a report on Wednesday, November 13th.

Quanterix Price Performance

Shares of QTRX stock opened at $11.97 on Friday. The stock has a market cap of $459.41 million, a PE ratio of -11.40 and a beta of 1.30. The stock has a 50-day moving average of $12.57 and a 200-day moving average of $13.43. Quanterix Co. has a one year low of $10.50 and a one year high of $29.70.

Quanterix Profile

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.